Cancer patient first in Canada to be treated with a rare radioisotope
A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a patient with neuroendocrine tumours (NETs) – a rare form of cancer – using a radioisotope (an atom that releases radiation) called actinium-225